EUVIMEDEUVIMED entdecken
Crossref

Revealing the effect of bromelain and donepezil against scopolamine-induced behavioral and histological changes in the brain

Tabarek Abd-Alrhman Ahmed, Buthina A. Abdulla, Wassan Sarhan Oubeid

Tikrit Journal of Veterinary Science · 30.06.2026 · 5 (1) · 55-61

DOI: 10.25130/tjvs.5.1.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tikrit Journal of Veterinary Science, online erschienen am 30.06.2026. Verfasst von Tabarek Abd-Alrhman Ahmed und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & aim: Alzheimer’s disease is a progressive neurodegenerative disorder characterized by memory impairment and cognitive dysfunction. Scopolamine is commonly used to induce Alzheimer’s-like changes in experimental animals. Therefore, the present study aimed to evaluate the protective effects of bromelain and donepezil against scopolamine-induced behavioral and histopathological alterations in the brain of adult female rats.Materials and Methods: Twenty-five adult female rats aged 10–12 weeks and weighing 181–204 g were used in this study. The experiment was conducted at the Animal House, College of Veterinary Medicine, Tikrit University, from August 29 to September 11, 2024. The rats were randomly divided into five groups. The control group received normal saline for 14 days. The scopolamine group received 0.02 mg/kg intraperitoneally from days 8–14. The remaining groups were pretreated with bromelain for 7 days, followed by concurrent administration of scopolamine with donepezil, bromelain, or their combination during days 8–14.

Results

Behavioral assessment using the T-maze test demonstrated that scopolamine-treated rats exhibited marked cognitive impairment and reduced exploratory behavior. In contrast, rats treated with bromelain and/or donepezil showed significant improvement in maze performance, exploratory activity, and cognitive function, with the combination-treated group exhibiting the greatest improvement. Histological examination of the scopolamine group revealed severe neuronal degeneration, large cavities in the brain medulla, hyperplastic glial cells, vascular congestion, vacuolation, and inflammatory cell infiltration. Treatment with bromelain or donepezil markedly preserved neuronal architecture, reduced vacuolar degeneration and inflammatory infiltration, and restored the normal organization of the pyramidal cell layers. The combined treatment produced the most pronounced histological improvement.

Conclusions

It is concluded that bromelain exerts a neuroprotective effect against scopolamine-induced behavioral and histopathological changes. Bromelain, particularly when combined with donepezil, improves cognitive performance, preserves brain tissue integrity, and reduces neuronal degeneration and inflammatory responses, suggesting its potential as an adjunctive therapeutic agent for Alzheimer ‘disease.

Zitieren

APA

Ahmed, T. A., Abdulla, B. A., & Oubeid, W. S. (2026). Revealing the effect of bromelain and donepezil against scopolamine-induced behavioral and histological changes in the brain. Tikrit Journal of Veterinary Science, 5(1), 55-61. https://doi.org/10.25130/tjvs.5.1.7

Vancouver

Ahmed TA, Abdulla BA, Oubeid WS. Revealing the effect of bromelain and donepezil against scopolamine-induced behavioral and histological changes in the brain. Tikrit Journal of Veterinary Science. 2026;5(1):55-61. doi:10.25130/tjvs.5.1.7

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Tabarek Abd-Alrhman and Abdulla, Buthina A. and Oubeid, Wassan Sarhan},
  title = {Revealing the effect of bromelain and donepezil against scopolamine-induced behavioral and histological changes in the brain},
  journal = {Tikrit Journal of Veterinary Science},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {55--61},
  doi = {10.25130/tjvs.5.1.7}
}
Kostenlos starten →